Management of borderline resectable pancreatic cancer

Table 1 Criteria for resectability

	NCCN	AHPBA/SSAT/SSO	MD Anderson	Intergroup (Alliance)
Celiac artery	No abutment for pancreatic head cancer. For body/tail, ≤ 180° contact	No abutment or encasement	Abutment	Tumor-vessel interface < 180° of vessel wall circumference
CHA	Solid tumor contact ≤ 180° allowing for reconstruction	Abutment or short segment encasement	Abutment or short-segment encasement	Reconstructable short-segment interface of any degree
SMA	Solid tumor contact ≤ 180°	Abutment	Abutment	Tumor-vessel wall interface < 180° of vessel wall circumference
SMV/PV	Solid tumor contact > 180° or contact of ≤ 180° with contour irregularity or thrombosis allowing for safe reconstruction	Occlusion	Occlusion	Tumor-vessel interface ≥ 180° of vessel wall circumference and/or reconstructible occlusion

CHA: Common hepatic artery; SMA: Superior mesenteric artery; SMV: Superior mesenteric vein; PV: Portal vein; NCCN: National Comprehensive Cancer Network; AHPBA/SSAT/SSO: Americas Hepato-Pancreato-Biliary Association/Society for Surgery of the Alimentary Tract/Society of Surgical Oncology.